Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

NASDAQ:CLNE - Nasdaq - US1844991018 - Common Stock - Currency: USD

1.54  +0.06 (+4.05%)

After market: 1.54 0 (0%)

Fundamental Rating

3

CLNE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 212 industry peers in the Oil, Gas & Consumable Fuels industry. CLNE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLNE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CLNE was profitable.
CLNE had a positive operating cash flow in the past year.
In the past 5 years CLNE always reported negative net income.
In the past 5 years CLNE always reported a positive cash flow from operatings.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

CLNE's Return On Assets of -6.68% is on the low side compared to the rest of the industry. CLNE is outperformed by 82.08% of its industry peers.
With a Return On Equity value of -11.65%, CLNE is not doing good in the industry: 76.89% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -6.68%
ROE -11.65%
ROIC N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

CLNE's Gross Margin of 30.86% is in line compared to the rest of the industry. CLNE outperforms 40.57% of its industry peers.
CLNE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLNE has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for CLNE has been increased compared to 5 years ago.
The debt/assets ratio for CLNE is higher compared to a year ago.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.26, we must say that CLNE is in the distress zone and has some risk of bankruptcy.
CLNE's Altman-Z score of -0.26 is on the low side compared to the rest of the industry. CLNE is outperformed by 72.64% of its industry peers.
CLNE has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
CLNE's Debt to Equity ratio of 0.37 is in line compared to the rest of the industry. CLNE outperforms 54.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -0.26
ROIC/WACCN/A
WACC11.5%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.67 indicates that CLNE has no problem at all paying its short term obligations.
The Current ratio of CLNE (2.67) is better than 81.13% of its industry peers.
CLNE has a Quick Ratio of 2.39. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
CLNE has a better Quick ratio (2.39) than 80.66% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.39
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

CLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 166.67%, which is quite impressive.
The earnings per share for CLNE have been decreasing by -21.00% on average. This is quite bad
The Revenue has decreased by -2.19% in the past year.
The Revenue has been growing slightly by 3.86% on average over the past years.
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%100%
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%2.31%

3.2 Future

Based on estimates for the next years, CLNE will show a very strong growth in Earnings Per Share. The EPS will grow by 65.71% on average per year.
Based on estimates for the next years, CLNE will show a very strong growth in Revenue. The Revenue will grow by 22.39% on average per year.
EPS Next Y-1156.06%
EPS Next 2Y-174.32%
EPS Next 3Y-74.66%
EPS Next 5Y65.71%
Revenue Next Year-3.48%
Revenue Next 2Y3.83%
Revenue Next 3Y0.81%
Revenue Next 5Y22.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.50, the valuation of CLNE can be described as expensive.
Based on the Price/Earnings ratio, CLNE is valued a bit more expensive than 66.04% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.22, CLNE is valued a bit more expensive.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 38.5
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

67.45% of the companies in the same industry are cheaper than CLNE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.29
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A cheap valuation may be justified as CLNE's earnings are expected to decrease with -74.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-174.32%
EPS Next 3Y-74.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLNE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (5/2/2025, 8:00:00 PM)

After market: 1.54 0 (0%)

1.54

+0.06 (+4.05%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)05-08 2025-05-08/amc
Inst Owners51.01%
Inst Owner Change-0.18%
Ins Owners0.86%
Ins Owner Change0.88%
Market Cap344.90M
Analysts84
Price Target6.55 (325.32%)
Short Float %6.52%
Short Ratio3.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)184.91%
Min EPS beat(2)184.05%
Max EPS beat(2)185.77%
EPS beat(4)4
Avg EPS beat(4)143.95%
Min EPS beat(4)77.37%
Max EPS beat(4)185.77%
EPS beat(8)7
Avg EPS beat(8)132.68%
EPS beat(12)10
Avg EPS beat(12)85.21%
EPS beat(16)11
Avg EPS beat(16)94.7%
Revenue beat(2)2
Avg Revenue beat(2)3.33%
Min Revenue beat(2)2.21%
Max Revenue beat(2)4.45%
Revenue beat(4)3
Avg Revenue beat(4)-0.29%
Min Revenue beat(4)-9.94%
Max Revenue beat(4)4.45%
Revenue beat(8)4
Avg Revenue beat(8)0.91%
Revenue beat(12)5
Avg Revenue beat(12)-1.58%
Revenue beat(16)7
Avg Revenue beat(16)-7.49%
PT rev (1m)-4.22%
PT rev (3m)-7.89%
EPS NQ rev (1m)-6.52%
EPS NQ rev (3m)-298.61%
EPS NY rev (1m)-13.73%
EPS NY rev (3m)-321.17%
Revenue NQ rev (1m)-2.97%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-3.1%
Revenue NY rev (3m)-5.55%
Valuation
Industry RankSector Rank
PE 38.5
Fwd PE N/A
P/S 0.83
P/FCF N/A
P/OCF 5.34
P/B 0.48
P/tB 0.54
EV/EBITDA 15.29
EPS(TTM)0.04
EY2.6%
EPS(NY)-0.42
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.29
OCFY18.72%
SpS1.86
BVpS3.18
TBVpS2.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.68%
ROE -11.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.86%
FCFM N/A
ROA(3y)-6.67%
ROA(5y)-6.22%
ROE(3y)-11.16%
ROE(5y)-9.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.4%
GM growth 5Y-4.26%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 16.2
Cap/Depr 178.73%
Cap/Sales 19.23%
Interest Coverage N/A
Cash Conversion 391.72%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.39
Altman-Z -0.26
F-Score4
WACC11.5%
ROIC/WACCN/A
Cap/Depr(3y)180.71%
Cap/Depr(5y)126.79%
Cap/Sales(3y)20.16%
Cap/Sales(5y)15.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%100%
EPS Next Y-1156.06%
EPS Next 2Y-174.32%
EPS Next 3Y-74.66%
EPS Next 5Y65.71%
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y17.62%
Revenue growth 5Y3.86%
Sales Q2Q%2.31%
Revenue Next Year-3.48%
Revenue Next 2Y3.83%
Revenue Next 3Y0.81%
Revenue Next 5Y22.39%
EBIT growth 1Y63.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year258.77%
EBIT Next 3Y85.78%
EBIT Next 5Y50.31%
FCF growth 1Y80.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.52%
OCF growth 3Y16.07%
OCF growth 5Y39.37%